
Celebrating National Cancer Survivor Day
Today we celebrate National Cancer Survivors Day, honoring the strength and resilience of those who have faced cancer. This day
(All Locations)
Wednesday, Nov. 25: 7:30 AM – 4:30 PM Thursday, Nov. 26: Closed Friday, Nov. 27: Closed
Thursday, Dec. 24: 7:30 AM – 4:30 PM Friday, Dec. 25: Closed
Thursday, Dec. 31: 7:30 AM – 4:30 PM Friday, Jan. 1: Closed
LAFAYETTE, LA — August 1, 2026 — OncoLogics, a premier provider of advanced cancer care across the Acadiana region, today announced a new collaboration with JointGlow to offer low-dose radiotherapy (LDRT) to patients suffering from chronic musculoskeletal pain, osteoarthritis and inflammatory tissue disorders. LDRT is an FDA-cleared, highly effective, non-invasive joint pain treatment option offering patients long-term relief without surgery or steroids.
Through this innovative collaboration, OncoLogics will deliver the proprietary JointGlow LDRT protocol with its state-of-the-art linear accelerators and radiotherapy equipment.
The treatment experience is painless, non-invasive, and seamless. Using ultra-low doses of energy, LDRT targets the joint at the cellular level, prompting overactive, pro-inflammatory immune cells to switch to an anti-inflammatory “repair” state.
The efficacy of LDRT is supported by substantial data. Peer-reviewed clinical studies show high success rates for difficult-to-treat areas, such as knee osteoarthritis and chronic plantar fasciitis.
By applying established radiotherapy frameworks to benign musculoskeletal conditions, OncoLogics is extending its reach to more patients in Acadiana.
“We know that many patients are frustrated by chronic joint pain and are searching for alternatives to surgery or ongoing injections,” said Dr. Jonathan Thompson, Certified Physician in Low Dose Radiotherapy at OncoLogics. “Collaborating with JointGlow allows us to offer a treatment that fits naturally into our care model and provides another option for people who want relief without an invasive procedure. We’re excited to make this available to the communities we serve.”
“Living with chronic joint pain can affect just about every part of a person’s daily life,” said JointGlow Founder and CEO Gokul Solai, MD. “We’re pleased to collaborate with OncoLogicsto give patients a treatment option that addresses underlying inflammation and produces results that can last longer than traditional approaches.”
To schedule a consultation, visit https://oncologics.net/contact-us/.

Today we celebrate National Cancer Survivors Day, honoring the strength and resilience of those who have faced cancer. This day

The holiday season is often associated with joy, celebration, and togetherness. However, for those navigating a cancer diagnosis, it can

The holiday season can be joyful—but for those facing cancer, it can also feel overwhelming. It’s okay to need support,

As we commemorate National Cancer Prevention Month, it is crucial to recognize the importance of early detection and screening in

Cancer is a word that carries immense weight, affecting millions of lives every year. While it’s true that some risk

October is a reminder not just to wear pink, but to take meaningful steps toward protecting your health.

Head and neck cancer is a term used to describe a variety of cancers that occur in the head and
Lafayette, La. — May 27, 2026 — OncoLogics today announced the installation and launch of a next-generation radiation therapy platform at its Our Lady of Lourdes location, further strengthening access to sophisticated cancer treatment technology for patients across Lafayette and Acadiana.